In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

The criminal justice forensic sector has been strengthened thanks to an acquisition deal brokered by Crawley-based corporate finance specialists Watersheds.

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

The company announced Monday that it would lay off around 40% of its workforce -- about 200 employees -- and close its drug ...

Lin said he went through two or three iterations of testing nearly 100 potential solutions before he found one that could be ...

Conversely, the COVID-19 vaccines' rapid development was thanks to expert production and testing ... pharmaceutical ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

As genetic testing becomes more available, patients are gaining unprecedented access to information about the likelihood of diseases and medical conditions. There is increased demand for professionals ...